Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01698528 · ClinicalTrials.gov registry record · NA

Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and Titration

A NA study of Type II Diabetes, sponsored by Joslin Diabetes Center.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT01698528 is a NA study of Type II Diabetes that has completed, run by Joslin Diabetes Center. The registered enrollment target is 40 participants, below the 675-participant average among 6 other Type II Diabetes trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01698528, a NA study of Type II Diabetes, has completed, sponsored by Joslin Diabetes Center.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if using a diabetes management technology system, including a tablet computer, to track diabetes care and communicate with a clinician coach (a doctor or nurse from the Joslin Clinic) makes starting and adjusting insulin easier and safer for people with type 2 diabetes. Hypothesis: The use of a diabetes management technology system with a clinician coach helps more individuals starting basal insulin achieve better glycemic control with less hypoglycemia compared with standard clinical practice at Joslin Diabetes Center.

Conditions Studied

Interventions

  • DEVICE Tablet Computer

Study Locations (1)

Massachusetts

  • Joslin Diabetes Center - Boston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2012-10
Est. Completion 2015-10
Phase NA

Sponsor

Joslin Diabetes Center

73 total trials

What the Registry Record Tells You About NCT01698528

The ClinicalTrials.gov registry entry for NCT01698528 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 675-participant average among 6 other Type II Diabetes trials with a reported enrollment target (94% lower). The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type II Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Tablet Computer is the first listed.

NCT01698528 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01698528 about?

NCT01698528 is a clinical study titled "Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and Titration". The purpose of this study is to determine if using a diabetes management technology system, including a tablet computer, to track diabetes care and communicate with a clinician coach (a doctor or nurse from the Joslin Clinic) makes starting and adjusting insulin easier and safer for people with type...

What is the current status of trial NCT01698528?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2012-10. Estimated completion is 2015-10.

What conditions does trial NCT01698528 study?

This clinical trial studies the following conditions: Type II Diabetes.

What interventions are being tested in trial NCT01698528?

The interventions under investigation include: Tablet Computer (DEVICE).

Who is sponsoring clinical trial NCT01698528?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01698528 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type II Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.